Glaxo snaps up US vaccine maker Affinivax in £2.6bn deal
Affinivax is developing a vaccine to combat pneumococcal diseases which include pneumonia and meningitis as well as milder illnesses such as sinusitis.
Source: thisismoney.co.uk
Page 4 - Max Herrmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Max Herrmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Max Herrmann Today - Breaking & Trending Today
Valneva SE (VALN) CEO Thomas Lingelbach on Q1 2022 Results - Earnings Call Transcript
Valneva SE (NASDAQ:NASDAQ:VALN) Q1 2022 Earnings Conference Call May 5, 2022 10:00 AM ET Company Participants Thomas Lingelbach - Chief Executive Officer Peter Buhler - Chief Financial...
Source: seekingalpha.com
Amryt Pharma PLC (AMYT) CEO Joseph Wiley on Q1 2022 Results - Earnings Call Transcript
Amryt Pharma PLC (NASDAQ:NASDAQ:AMYT) Q1 2022 Earnings Conference Call May 04, 2022, 08:30 ET Company Participants Simon Loughrey - Group Financial Controller Joseph Wiley - CEO &...
Source: seekingalpha.com
Valneva SE (VALN) Q1 2022 Earnings Call Transcript
VALN earnings call for the period ending March 31, 2022.
Source: fool.com
Indivior PLC (INVVY) CEO Mark Crossley on Q1 2022 Results - Earnings Call Transcript
Indivior PLC (OTCPK:INVVY) Q1 2022 Results Earnings Conference Call April 28, 2022, 08:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial...
Source: seekingalpha.com